gefitinib Aug 27, 2020 Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications Sep 29, 2019 Combination Immunotherapy, Third-Generation TKI Improve Survival in Advanced Lung Cancer Jul 23, 2019 China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples Jun 2, 2019 ASCO Studies Highlight Potential of Antibodies in Overcoming Anti-EGFR Rx Resistance in NSCLC Premium Aug 23, 2018 FDA Approves Roche Cobas EGFR Mutation Test as CDx for Iressa May 24, 2018 Lung Cancer Study Investigates Role of Protein Modifications in Cell Signaling, Drug Response Premium Jun 27, 2016 Precision Lung Cancer Drugs on Pricing Evaluation Group's Agenda Premium Jul 14, 2015 Iressa Approval Grows Options for Lung Cancer Patients as AstraZeneca Re-establishes Presence Premium Jul 13, 2015 FDA Approves Qiagen's Therascreen EGFR Test as CDx for AstraZeneca NSCLC Drug Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma
